Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
OrganiGram Holdings (OGI)
NASDAQ:OGI
RESEARCH TOOLSreports
Holding OGI?
Track your performance easily
Earnings Data
Report Date
Apr 15, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
―Last Year’s EPS
-0.09Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 30, 2018
|% Change Since: -1.27%
|Next Earnings Date:Jul 30, 2018
Earnings Call Sentiment|Positive
The earnings call highlighted strong fiscal performance with notable achievements in EBITDA growth, international expansion, and strategic acquisitions. However, challenges such as a net loss in Q4 and expected market competition were also acknowledged.Company Guidance
During the Organigram Holdings Q4 2024 earnings call, the company provided several key metrics and guidance for future performance. The fiscal year 2024 saw a 55% growth in full-year adjusted EBITDA, signaling robust financial health. In Q4, the company reported net revenue of $44.7 million, up 22% year-over-year, and achieved an adjusted gross margin of 37%. The market share in the Canadian cannabis market rose to 7.6% in September, driven by a 17.6% year-over-year increase in recreational shipments. Organigram also maintained strong positions in gummies and hash with market shares of 20.9% and 22.6%, respectively. The acquisition of Motif is expected to add approximately $86 million in net revenue and generate $10 million in cost synergies within 24 months. For fiscal 2025, the company anticipates stabilizing gross margins above 35% and achieving positive adjusted EBITDA in most reporting periods, with a further focus on international expansion and operational efficiencies.Strong Adjusted EBITDA Growth
Reported a full year adjusted EBITDA growth of 55% over the prior year, reaching $8.4 million.
International Expansion
Expanded global reach to 8 international supply partners and completed first shipments to Germany and UK, signaling growing international footprint.
Successful Acquisition of Motif
Acquired Motif, enhancing revenue and earnings potential, and adding approximately $86 million in run rate net revenue.
Market Share Gains
Held the #2 market share position in the Canadian cannabis market, with 7.6% market share in September.
Innovation in Product Development
Launched Fast Acting Soluble Technology for ingestible products, backed by a $3 million pharmacokinetic study.
---
OGI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
OGI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Jan 14, 2025 | $1.57 | $1.53 | -2.55% |
| Dec 18, 2024 | $1.61 | $1.47 | -8.70% |
| Aug 13, 2024 | $1.44 | $1.81 | +25.69% |
| May 14, 2024 | $1.84 | $1.84 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does OrganiGram Holdings (OGI) report earnings?
OrganiGram Holdings (OGI) is schdueled to report earning on Apr 15, 2025, TBA Not Confirmed.
What is OrganiGram Holdings (OGI) earnings time?
OrganiGram Holdings (OGI) earnings time is at Apr 15, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OGI EPS forecast?
Currently, no data Available
---